{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:50:49Z","timestamp":1790380249688,"version":"4.1.0"},"reference-count":173,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Hyperprolactinemia can be caused by several conditions and its effects on the hypothalamic-pituitary-gonadal axis are understood in more detail. Nevertheless, in recent decades, other metabolic effects have been studied and data pointed to a potential increased cardiovascular disease (CVD) risk. A recent study showed a decrease in total and LDL- cholesterol only in men with prolactinoma treated with dopamine agonists (DA) supporting the previous results of a population study with increased CVD risk in men harboring prolactinoma. However, other population studies did not find a correlation between prolactin (PRL) levels and CVD risk or mortality. There is also data pointing to an increase in high-density lipoprotein levels, and decreases in triglycerides, carotid-intima-media thickness, C-reactive protein, and homocysteine levels in patients with prolactinoma on DA treatment. PRL was also implicated in endothelial dysfunction in pre and postmenopausal women. Withdrawal of DA resulted in negative changes in vascular parameters and an increase in plasma fibrinogen. It has been shown that PRL levels were positively correlated with blood pressure and inversely correlated with dilatation of the brachial artery and insulin sensitivity, increased homocysteine levels, and elevated D-dimer levels. Regarding possible mechanisms for the association between hyperprolactinemia and CVD risk, they include a possible direct effect of PRL, hypogonadism, and even effects of DA treatment, independently of changes in PRL levels. In conclusion, hyperprolactinemia seems to be associated with impaired endothelial function and DA treatment could improve CVD risk. More studies evaluating CVD risk in hyperprolactinemic patients are important to define a potential indication of treatment beyond hypogonadism.<\/jats:p>","DOI":"10.3389\/fendo.2022.1018090","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T15:38:44Z","timestamp":1673365124000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["The interplay between prolactin and cardiovascular disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Andrea","family":"Glezer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Ramos","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello D.","family":"Bronstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Jose","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Soares","family":"Jallad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199311000-00016","article-title":"Dopamine inhibits growth hormone and prolactin secretion in the human newborn","volume":"34","author":"De Zegher","year":"1993","journal-title":"Pediatr Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.19.3.0334","article-title":"Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice","volume":"19","author":"Bole-Feysot","year":"1998","journal-title":"Endocr Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00025","article-title":"Actions of prolactin in the brain: From physiological adaptations to stress and neurogenesis to psychopathology","volume":"7","author":"Torner","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1831","article-title":"Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay","volume":"91","author":"Glezer","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00342","article-title":"From bench to bedside: Translating the Prolactin\/Vasoinhibin axis","volume":"8","author":"Triebel","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2014.11.003","article-title":"Prolactinomas","volume":"44","author":"Glezer","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01039-x","article-title":"Do nothing but observe microprolactinomas: when and how to replace sex hormones","volume":"23","author":"Bonert","year":"2020","journal-title":"Pituitary"},{"key":"B9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11102-019-00998-0","article-title":"Prolactinomas and menopause: any changes in management","volume":"23","author":"Greenman","year":"2020","journal-title":"Pituitary"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.009","article-title":"The global burden of cardiovascular diseases and risk factors: 2020 and beyond","volume":"74","author":"Mensah","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12471-017-0959-2","article-title":"Pathophysiology and treatment of atherosclerosis : Current view and future perspective on lipoprotein modification treatment","volume":"25","author":"Bergheanu","year":"2017","journal-title":"Neth Heart J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.306825","article-title":"Epidemiology of obesity and diabetes and their cardiovascular complications","volume":"118","author":"Bhupathiraju","year":"2016","journal-title":"Circ Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.01.039","article-title":"Evaluation and practical management of increased visceral fat: Should cardiologists lose sleep over it","volume":"79","author":"Bays","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175204","article-title":"Association between serum prolactin levels and insulin resistance in non-diabetic men","volume":"12","author":"Daimon","year":"2017","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13098-015-0094-4","article-title":"Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline","volume":"7","author":"Pala","year":"2015","journal-title":"Diabetol Metab Syndr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00403.x","article-title":"Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels","volume":"48","author":"Greenman","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02973.x","article-title":"Body fat in nonobese women with prolactinoma treated with dopamine agonists","volume":"67","author":"Naliato","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygcen.2020.113589","article-title":"Osmoregulatory actions of prolactin in the gastrointestinal tract of fishes","volume":"298","author":"Breves","year":"2020","journal-title":"Gen Comp Endocrinol"},{"key":"B21","article-title":"[Role of prolactin in disorders of water and salt metabolism in patients with hypertension]","volume":"26","author":"Ziabreva","year":"1986","journal-title":"Kardiologiia"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(71)90065-1","article-title":"Actions of prolactin on human renal function","volume":"2","author":"Horrobin","year":"1971","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(76)90004-4","article-title":"Hyperprolactinemia influences renal function in man","volume":"25","author":"Buckman","year":"1976","journal-title":"Metabolism"},{"key":"B24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2169\/internalmedicine1962.24.19","article-title":"Plasma prolactin levels in patients with essential hypertension, malignant hypertension and secondary hypertension","volume":"24","author":"Tanaka","year":"1985","journal-title":"Jpn J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF00932973","article-title":"Relationship between serum prolactin concentration, vascular angiotensin sensitivity and arterial blood pressure during third trimester pregnancy","volume":"243","author":"Oney","year":"1988","journal-title":"Arch Gynecol Obstet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328339f254","article-title":"Plasma prolactin level and risk of incident hypertension in postmenopausal women","volume":"28","author":"Zhang","year":"2010","journal-title":"J Hypertens"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0305","article-title":"Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes","volume":"93","author":"Lea\u00f1os-Miranda","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.00754","article-title":"Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia","volume":"61","author":"Lea\u00f1os-Miranda","year":"2013","journal-title":"Hypertension"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.35.4.558","article-title":"Maternal and cord blood prolactin level and pregnancy complications","volume":"35","author":"Alawad","year":"2019","journal-title":"Pak J Med Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1615051113","article-title":"Prolactin alters blood pressure by modulating the activity of endothelial nitric oxide synthase","volume":"113","author":"Chang","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01036.2007","article-title":"Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice","volume":"294","author":"Zeng","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/HYPERTENSIONAHA.109.132100","article-title":"Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors","volume":"54","author":"Georgiopoulos","year":"2009","journal-title":"Hypertension"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4103\/njcp.njcp_178_20","article-title":"Is idiopathic mild hyperprolactinemia a cardiovascular risk factor","volume":"24","author":"Koca","year":"2021","journal-title":"Niger J Clin Pract"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1982.tb00731.x","article-title":"Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma","volume":"16","author":"Pelkonen","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03752.x","article-title":"Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma","volume":"73","author":"Erem","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-4-288","article-title":"Elevated serum lipids in hypogonadal men with and without hyperprolactinemia","volume":"111","author":"Oppenheim","year":"1989","journal-title":"Ann Intern Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3109\/07435800.2015.1135444","article-title":"Obesity and hypercholesterolemia in patients with prolactinomas: Could DHEA-s and growth hormone be the missing link","volume":"41","author":"Peri\u0107","year":"2016","journal-title":"Endocr Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11102-010-0277-9","article-title":"Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy","volume":"14","author":"Berinder","year":"2011","journal-title":"Pituitary"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12307","article-title":"Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels","volume":"116","author":"Krysiak","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.2.285","article-title":"The lipoprotein profile of women with hyperprolactinaemic amenorrhoea","volume":"14","author":"Fahy","year":"1999","journal-title":"Hum Reprod"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-016-9882-2","article-title":"Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas","volume":"32","author":"Schwetz","year":"2017","journal-title":"Metab Brain Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2015.01.024","article-title":"Risk factors for accelerated atherosclerosis in young women with hyperprolactinemia","volume":"84","author":"Medic-Stojanoska","year":"2015","journal-title":"Med Hypotheses"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9857-y","article-title":"Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma","volume":"44","author":"Inancli","year":"2013","journal-title":"Endocrine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17824","article-title":"Change in insulin sensitivity and lipid profile after dopamine agonist therapy in patients with prolactinoma","volume":"13","author":"Khalil","year":"2021","journal-title":"Cureus"},{"key":"B45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000357810","article-title":"Effect of cabergoline on metabolism in prolactinomas","volume":"98","author":"Auriemma","year":"2013","journal-title":"Neuroendocrinology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2010.150","article-title":"BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists","volume":"19","author":"dos Santos Silva","year":"2011","journal-title":"Obes (Silver Spring)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000371851","article-title":"Effect of chronic cabergoline treatment and testosterone replacement on metabolism in male patients with prolactinomas","volume":"101","author":"Auriemma","year":"2015","journal-title":"Neuroendocrinology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12204","article-title":"Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels","volume":"79","author":"Ciresi","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12902-021-00733-6","article-title":"Adverse body composition and lipid parameters in patients with prolactinoma: A case-control study","volume":"21","author":"Posawetz","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-013-0495-z","article-title":"Increased carotid intima media thickness is associated with prolactin levels in subjects with untreated prolactinoma: A pilot study","volume":"17","author":"Jiang","year":"2014","journal-title":"Pituitary"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/BF01721038","article-title":"Chronic hyperprolactinemia and plasma lipids in women","volume":"65","author":"Heshmati","year":"1987","journal-title":"Klin Wochenschr"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021137","article-title":"Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue","volume":"88","author":"Ling","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.11.1697","article-title":"Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women","volume":"20","author":"Kamath","year":"1997","journal-title":"Diabetes Care"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.769744","article-title":"Effects of pituitary surgery and high-dose cabergoline therapy on metabolic profile in patients with prolactinoma resistant to conventional cabergoline treatment","volume":"12","author":"Pirchio","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1301","article-title":"Different effects of atorvastatin on cardiometabolic risk factors in young women with and without hyperprolactinemia","volume":"59","author":"Krysiak","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2019.0013","article-title":"Cardiometabolic risk factors in young women with macroprolactinaemia","volume":"70","author":"Krysiak","year":"2019","journal-title":"Endokrynol Pol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.07.017","article-title":"Impact of macroprolactinemia on cardiometabolic effects of atorvastatin in women with hypercholesterolemia","volume":"124","author":"Krysiak","year":"2019","journal-title":"Am J Cardiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/a-0902-4439","article-title":"Cardiometabolic risk factors in men with elevated macroprolactin content: A pilot study","volume":"129","author":"Krysiak","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4158\/EP13173.OR","article-title":"Preclinical atherosclerosis in patients with prolactinoma","volume":"20","author":"Arslan","year":"2014","journal-title":"Endocr Pract"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-10-0076","article-title":"The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: A role for prolactin in atherogenesis","volume":"208","author":"Reuwer","year":"2011","journal-title":"J Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mce.2005.01.005","article-title":"Prolactin-induced expression of vascular endothelial growth factor via egr-1","volume":"232","author":"Goldhar","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-1577","article-title":"Prolactin induces regional vasoconstriction through the beta2-adrenergic and nitric oxide mechanisms","volume":"148","author":"Molinari","year":"2007","journal-title":"Endocrinology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(92)90110-h","article-title":"Prolactin induces growth-related gene expression in rat aortic smooth muscle in vivo","volume":"225","author":"Sauro","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490187","article-title":"Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women","volume":"149","author":"Yavuz","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.5152\/AnatolJCardiol.2015.6416","article-title":"Evaluation of atherosclerosis after cessation of cabergoline therapy in patients with prolactinoma","volume":"16","author":"Do\u011fan","year":"2016","journal-title":"Anatol J Cardiol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.23030","article-title":"Is there an increased cardiovascular risk in patients with prolactinoma? a challenging question","volume":"49","author":"Yazici","year":"2021","journal-title":"J Clin Ultrasound"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02469.x","article-title":"The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy","volume":"64","author":"Serri","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12143","article-title":"The effect of atorvastatin on cardiometabolic risk factors in bromocriptine-treated premenopausal women with isolated hypercholesterolemia","volume":"33","author":"Krysiak","year":"2015","journal-title":"Cardiovasc Ther"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1062724","article-title":"The double role of epicardial adipose tissue as pro- and anti-inflammatory organ","volume":"40","author":"Iacobellis","year":"2008","journal-title":"Horm Metab Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0171","article-title":"Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study","volume":"6","author":"Soto-Pedre","year":"2017","journal-title":"Endocr Connect"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13498","article-title":"Males with prolactinoma are at increased risk of incident cardiovascular disease","volume":"88","author":"Toulis","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.4.8722","article-title":"Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance","volume":"143","author":"Freemark","year":"2002","journal-title":"Endocrinology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2006.02.005","article-title":"Focus on prolactin as a metabolic hormone","volume":"17","author":"Ben-Jonathan","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1210\/endo.136.9.7649117","article-title":"Prolactin receptors and JAK2 in islets of langerhans: an immunohistochemical analysis","volume":"136","author":"Sorenson","year":"1995","journal-title":"Endocrinology"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00083","article-title":"Plasma prolactin and progesterone levels and the risk of gestational diabetes: A prospective and longitudinal study in a multiracial cohort","volume":"11","author":"Li","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/jdi.12634","article-title":"Higher maternal serum prolactin levels are associated with reduced glucose tolerance during pregnancy","volume":"8","author":"Ekinci","year":"2017","journal-title":"J Diabetes Investig"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2013.0009","article-title":"Prolactin receptor gene polymorphisms are associated with gestational diabetes","volume":"17","author":"Le","year":"2013","journal-title":"Genet Test Mol Biomarkers"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0144","article-title":"Maternal prolactin is associated with glucose status and PCOS in pregnancy: Odense child cohort","volume":"183","author":"Overgaard","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.03.045","article-title":"Prolactin effect on blood glucose and ins\u00fclin in breastfeeding women","volume":"13","author":"Ozisik","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.7978","article-title":"Lactation duration and progression to diabetes in women across the childbearing years: The 30-year CARDIA study","volume":"178","author":"Gunderson","year":"2018","journal-title":"JAMA Intern Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac346","article-title":"Prolactin and maternal metabolism in women with a recent GDM pregnancy and links to future T2D: The SWIFT study","volume":"107","author":"Zhang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2006.09.011","article-title":"Beneficial effects of prolactin and laminin on human pancreatic islet-cell cultures","volume":"263","author":"Labriola","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.7.8267","article-title":"Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5","volume":"142","author":"Fleenor","year":"2001","journal-title":"Endocrinology"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.02.031","article-title":"Immunomodulatory role of prolactin in diabetes development","volume":"9","author":"Cejkova","year":"2009","journal-title":"Autoimmun Rev"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1893","article-title":"Circulating prolactin associates with diabetes and impaired glucose regulation: A population-based study","volume":"36","author":"Wang","year":"2013","journal-title":"Diabetes Care"},{"key":"B86","article-title":"Association of serum prolactin level with impaired glucose regulation and diabetes","volume":"65","author":"Chahar","year":"2017","journal-title":"J Assoc Physicians India"},{"key":"B87","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1210\/en.2016-1444","article-title":"Prolactin promotes adipose tissue fitness and insulin sensitivity in obese males","volume":"158","author":"Ruiz-Herrera","year":"2017","journal-title":"Endocrinology"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-013-0493-7","article-title":"Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans","volume":"51","author":"Wagner","year":"2014","journal-title":"Acta Diabetol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23721","article-title":"Association of serum prolactin with type 2 diabetes mellitus: A comparative cross-sectional study from south India","volume":"14","author":"Jayashankar","year":"2022","journal-title":"Cureus"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-13-12","article-title":"Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes","volume":"13","author":"Balbach","year":"2013","journal-title":"BMC Endocr Disord"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4733-9","article-title":"Circulating prolactin concentrations and risk of type 2 diabetes in US women","volume":"61","author":"Li","year":"2018","journal-title":"Diabetologia"},{"key":"B92","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/aje\/kwv326","article-title":"Circulating prolactin and risk of type 2 diabetes: A prospective study","volume":"184","author":"Wang","year":"2016","journal-title":"Am J Epidemiol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0043","article-title":"Maternal serum prolactin and prediction of postpartum \u03b2-cell function and risk of Prediabetes\/Diabetes","volume":"39","author":"Retnakaran","year":"2016","journal-title":"Diabetes Care"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002640","article-title":"Association between prolactin and incidence of cardiovascular risk factors in the framingham heart study","volume":"5","author":"Therkelsen","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108247","article-title":"Association between variations of physiological prolactin serum levels and the risk of type 2 diabetes: A systematic review and meta-analysis","volume":"166","author":"Faria de Castro","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B96","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF00745135","article-title":"Prolactin: a diabetogenic hormone","volume":"13","author":"Landgraf","year":"1977","journal-title":"Diabetologia"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-009-0183-1","article-title":"Evaluation of insulin sensitivity in hyperprolactinemic subjects by euglycemic hyperinsulinemic clamp technique","volume":"12","author":"Tuzcu","year":"2009","journal-title":"Pituitary"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-15-0528","article-title":"Hyperprolactinemia induced by hCG leads to metabolic disturbances in female mice","volume":"230","author":"Ratner","year":"2016","journal-title":"J Endocrinol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1215","article-title":"Serum prolactin concentrations determine whether they improve or impair \u03b2-cell function and insulin sensitivity in diabetic rats","volume":"27","author":"Park","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1159\/000336501","article-title":"Central prolactin modulates insulin sensitivity and insulin secretion in diabetic rats","volume":"95","author":"Park","year":"2012","journal-title":"Neuroendocrinology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1530\/eje.0.1470077","article-title":"Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine","volume":"147","author":"Doknic","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.01.004","article-title":"Time for a new perspective on prolactin in metabolism","volume":"31","author":"Macotela","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2010.01076.x","article-title":"Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction","volume":"34","author":"Corona","year":"2011","journal-title":"Int J Androl"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1080\/07420529309059707","article-title":"Circadian neuroendocrine role in age-related changes in body fat stores and insulin sensitivity of the male sprague-dawley rat","volume":"10","author":"Cincotta","year":"1993","journal-title":"Chronobiol Int"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12563","article-title":"Circadian peak dopaminergic activity response at the biological clock pacemaker (suprachiasmatic nucleus) area mediates the metabolic responsiveness to a high-fat diet","volume":"30","author":"Luo","year":"2018","journal-title":"J Neuroendocrinol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/dom.14183","article-title":"The effect of dopamine agonists on metabolic variables in adults with type 2 diabetes: A systematic review with meta analysis and trial sequential analysis of randomized clinical trials","volume":"23","author":"Andersen","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01424.x","article-title":"Why does quick-release bromocriptine decrease cardiac events","volume":"13","author":"Bell","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168851","article-title":"Bromocriptine-QR therapy reduces sympathetic tone and ameliorates a pro-Oxidative\/Pro-Inflammatory phenotype in peripheral blood mononuclear cells and plasma of type 2 diabetes subjects","volume":"23","author":"Cincotta","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar3752","article-title":"Striatal dopamine regulates systemic glucose metabolism in humans and mice","volume":"10","author":"Ter Horst","year":"2018","journal-title":"Sci Transl Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv014","article-title":"Reduced insulin sensitivity is related to less endogenous dopamine at D2\/3 receptors in the ventral striatum of healthy nonobese humans","volume":"18","author":"Caravaggio","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.883092","article-title":"Severe hyperprolactinemia promotes brown adipose tissue whitening and aggravates high fat diet induced metabolic imbalance","volume":"13","author":"Lopez-Vicchi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12888","article-title":"Metabolic functions of prolactin: Physiological and pathological aspects","volume":"32","author":"Lopez-Vicchi","year":"2020","journal-title":"J Neuroendocrinol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201902357R","article-title":"Chronic high prolactin levels impact on gene expression at discrete hypothalamic nuclei involved in food intake","volume":"34","author":"Lopez-Vicchi","year":"2020","journal-title":"FASEB J"},{"key":"B114","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11102-008-0097-3","article-title":"The effects of hyperprolactinemia on bone and fat","volume":"12","author":"Shibli-Rahhal","year":"2009","journal-title":"Pituitary"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00200.2016","article-title":"Chronic hyperprolactinemia evoked by disruption of lactotrope dopamine D2 receptors impacts on liver and adipocyte genes related to glucose and insulin balance","volume":"311","author":"Luque","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-5-35","article-title":"Compensatory weight gain due to dopaminergic hypofunction: new evidence and own incidental observations","volume":"5","author":"Reinholz","year":"2008","journal-title":"Nutr Metab (Lond)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.04.026","article-title":"Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue","volume":"331","author":"Nilsson","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.k06-026","article-title":"Hypoadiponectinemia in lean lactating women: Prolactin inhibits adiponectin secretion from human adipocytes","volume":"53","author":"Asai-Sato","year":"2006","journal-title":"Endocr J"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.749050","article-title":"The leptin system and diet: A mini review of the current evidence","volume":"12","author":"Mendoza-Herrera","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04954-0","article-title":"Dopamine subsystems that track internal states","volume":"608","author":"Grove","year":"2022","journal-title":"Nature"},{"key":"B121","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainres.2010.04.028","article-title":"Modulation of the mesolimbic dopamine system by leptin","volume":"1350","author":"Opland","year":"2010","journal-title":"Brain Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2016.03.046","article-title":"Effects of early and late neonatal bromocriptine treatment on hypothalamic neuropeptides, dopaminergic reward system and behavior of adult rats","volume":"325","author":"Carvalho","year":"2016","journal-title":"Neuroscience"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3390\/nu14183835","article-title":"Inflammation in VTA caused by HFD induces activation of dopaminergic neurons accompanied by binge-like eating","volume":"14","author":"Sun","year":"2022","journal-title":"Nutrients"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2020.112986","article-title":"Lateral hypothalamic area neuropeptides modulate ventral tegmental area dopamine neurons and feeding","volume":"223","author":"Perez-Bonilla","year":"2020","journal-title":"Physiol Behav"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1002\/eat.23776","article-title":"The neurobiological reward system and binge eating: A critical systematic review of neuroimaging studies","author":"Leenaerts","year":"2022","journal-title":"Int J Eat Disord"},{"key":"B126","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol Rev"},{"key":"B127","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cmet.2009.06.011","article-title":"Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding","volume":"10","author":"Leinninger","year":"2009","journal-title":"Cell Metab"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab410","article-title":"Central insulin modulates dopamine signaling in the human striatum","volume":"106","author":"Kullmann","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2021.102870","article-title":"Exploring the genetic correlation between obesity-related traits and regional brain volumes: Evidence from UK biobank cohort","volume":"33","author":"Pan","year":"2022","journal-title":"NeuroImage Clin"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(00)03643-6","article-title":"Brain dopamine and obesity","volume":"357","author":"Wang","year":"2001","journal-title":"Lancet"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/srep11283","article-title":"Emotional eating phenotype is associated with central dopamine D2 receptor binding independent of body mass index","volume":"5","author":"Eisenstein","year":"2015","journal-title":"Sci Rep"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12040486","article-title":"Molecular imaging of central dopamine in obesity: A qualitative review across substrates and radiotracers","volume":"12","author":"Janssen","year":"2022","journal-title":"Brain Sci"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113006","article-title":"Insulin actions in the mesolimbic dopamine system","volume":"320","author":"Liu","year":"2019","journal-title":"Exp Neurol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-8451","article-title":"Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones","volume":"33","author":"Baptista","year":"2000","journal-title":"Pharmacopsychiatry"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480325","article-title":"Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia","volume":"148","author":"Colao","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2826.2003.01092.x","article-title":"Changes in agouti-related peptide during the ring dove breeding cycle in relation to prolactin and parental hyperphagia","volume":"15","author":"Strader","year":"2003","journal-title":"J Neuroendocrinol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000054522","article-title":"Dopaminergic agonists normalize elevated hypothalamic neuropeptide y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob\/ob mice","volume":"71","author":"Bina","year":"2000","journal-title":"Neuroendocrinology"},{"key":"B138","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/17446651.2018.1434412","article-title":"The effects of hyperprolactinemia and its control on metabolic diseases","volume":"13","author":"Auriemma","year":"2018","journal-title":"Expert Rev Endocrinol Metab"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-107243","article-title":"Hyperprolactinemia and the association with all-cause mortality and cardiovascular mortality","volume":"49","author":"Krogh","year":"2017","journal-title":"Horm Metab Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092218","article-title":"Obesity and androgen receptor signaling: Associations and potential crosstalk in breast cancer cells","volume":"13","author":"Rangel","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-2111","article-title":"Androgen effects on adipose tissue architecture and function in nonhuman primates","volume":"153","author":"Varlamov","year":"2012","journal-title":"Endocrinology"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.09.053","article-title":"STAT 5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cells","volume":"324","author":"Stewart","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-204958","article-title":"Beige differentiation of adipose depots in mice lacking prolactin receptor protects against high-fat-diet-induced obesity","volume":"26","author":"Auffret","year":"2012","journal-title":"FASEB J"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.11.7147","article-title":"Prolactin stimulates leptin secretion by rat white adipose tissue","volume":"140","author":"Gualillo","year":"1999","journal-title":"Endocrinology"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021255","article-title":"Prolactin expression and secretion by human breast glandular and adipose tissue explants","volume":"88","author":"Zinger","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032184","article-title":"Prolactin release is enhanced in proportion to excess visceral fat in obese women","volume":"89","author":"Kok","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.2.6677","article-title":"Heparin-binding property of human prolactin: a novel aspect of prolactin biology","volume":"140","author":"Khurana","year":"1999","journal-title":"Endocrinology"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0040","article-title":"Circulating prolactin level is increased in metabolically healthy obesity","volume":"10","author":"Liu","year":"2021","journal-title":"Endocr Connect"},{"key":"B149","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1046\/j.1365-2265.1999.00700.x","article-title":"Hyperprolactinaemia as a reversible cause of weight gain in male patients","volume":"50","author":"Delgrange","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-15-0213","article-title":"60 years of neuroendocrinology: The hypothalamo-prolactin axis","volume":"226","author":"Grattan","year":"2015","journal-title":"J Endocrinol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1989.256.1.R276","article-title":"Prolactin stimulates food intake in a dose-dependent manner","volume":"256","author":"Gerardo-Gettens","year":"1989","journal-title":"Am J Physiol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0006-8993(96)00227-2","article-title":"The effect of central administration of prolactin on food intake in virgin female rats is dose-dependent, occurs in the absence of ovarian hormones and the latency to onset varies with feeding regimen","volume":"729","author":"Sauv\u00e9","year":"1996","journal-title":"Brain Res"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(00)02344-1","article-title":"Neuroanatomical specificity of prolactin-induced hyperphagia in virgin female rats","volume":"868","author":"Sauv\u00e9","year":"2000","journal-title":"Brain Res"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0442","article-title":"Prolactin\/Leptin interactions in the control of food intake in rats","volume":"148","author":"Naef","year":"2007","journal-title":"Endocrinology"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1055\/a-1020-3992","article-title":"Markers of metabolic syndrome in patients with pituitary adenoma: A case series of 303 patients","volume":"51","author":"Altunta\u015f","year":"2019","journal-title":"Horm Metab Res"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345636","article-title":"Body fat in men with prolactinoma","volume":"31","author":"Naliato","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2003.46","article-title":"Treatment with cabergoline is associated with weight loss in patients with hyperprolactinemia","volume":"11","author":"Korner","year":"2003","journal-title":"Obes Res"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0286","article-title":"Metabolic effects of dopamine agonists in patients with prolactinomas: A systematic review and meta-analysis","volume":"8","author":"Byberg","year":"2019","journal-title":"Endocr Connect"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2009.03.008","article-title":"Clinical profile and predictors of complications in peripartum cardiomyopathy","volume":"15","author":"Goland","year":"2009","journal-title":"J Card Fail"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020491","article-title":"Peripartum cardiomyopathy","volume":"133","author":"Arany","year":"2016","journal-title":"Circulation"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccep.2015.03.010","article-title":"Arrhythmias in peripartum cardiomyopathy","volume":"7","author":"Honigberg","year":"2015","journal-title":"Card Electrophysiol Clin"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.901496","article-title":"Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: A proof-of-concept pilot study","volume":"121","author":"Sliwa","year":"2010","journal-title":"Circulation"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx355","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: A multicentre randomized study","volume":"38","author":"Hilfiker-Kleiner","year":"2017","journal-title":"Eur Heart J"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06840711","article-title":"Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD","volume":"7","author":"Carrero","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs233","article-title":"Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality","volume":"35","author":"Haring","year":"2014","journal-title":"Eur Heart J"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9524839","article-title":"Relationship between prolactin, chronic kidney disease, and cardiovascular risk","volume":"2020","author":"Dourado","year":"2020","journal-title":"Int J Endocrinol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.109.853572","article-title":"Prolactin levels and the risk of future coronary artery disease in apparently healthy men and women","volume":"2","author":"Reuwer","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.002279","article-title":"Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects","volume":"1","author":"Gaziano","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.101","article-title":"Circadian-timed quick-release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus","volume":"3","author":"Chamarthi","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.8.1154","article-title":"Bromocriptine: a novel approach to the treatment of type 2 diabetes","volume":"23","author":"Pijl","year":"2000","journal-title":"Diabetes Care"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004818","article-title":"Effects of cabergoline on blood glucose levels in type 2 diabetic patients: A double-blind controlled clinical trial","volume":"95","author":"Bahar","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1159\/000486000","article-title":"Metabolic Syndrome in Hyperprolactinemia","volume":"49","author":"Andersen","year":"2018","journal-title":"Front Horm Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1018090\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T15:38:50Z","timestamp":1673365130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1018090\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":173,"alternative-id":["10.3389\/fendo.2022.1018090"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1018090","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"article-number":"1018090"}}